SCHEMBL14059902

SCHEMBL14059902

CN1CCN(c2c[c]cc(-c3ccccc3Cl)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ CLK4 Q9HAZ1 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HRH4 Q9H3N8 2/20 0.44
▸ HTR3A P46098 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ TDP2 O95551 1/20 0.40
▸ NSD2 O96028 1/20 0.40
▸ PLA2G1B P04054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14060017 0.86 ALDH1A1 (0.40) ALDH1A1LMNAMAPK1CNR2PIK3C3
SCHEMBL27943408 0.84 DRD2 (0.45) CYP1A2CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL27953793 0.83 CNR2 (0.52) HSD17B10ALDH1A1LMNATSHRMAPK1
SCHEMBL14060078 0.83 MEN1 (0.43) CYP1A2CYP2C19CYP3A4CYP2D6HSD17B10
SCHEMBL14060873 0.81 AR (0.38) ALDH1A1LMNACNR2PIK3C3PDE2A
SCHEMBL27943398 0.80 NCF1 (0.46) ALDH1A1MAPK1HTR3ADRD2DRD3
SCHEMBL14060358 0.78 HRH4 (0.47) ALDH1A1TSHRHRH4ADRA2CKCNH2
SCHEMBL27997452 0.77 HTR6 (0.46) CYP1A2CYP2C19ALDH1A1ALOX15HRH4
SCHEMBL27953748 0.76 CYP1A2 (0.46) CYP1A2CYP2C19CYP3A4CYP2D6HSD17B10
SCHEMBL27997677 0.76 AGXT (0.43) ALDH1A1HRH4HTR3ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104271576-A Pyridopyrimidinone inhibitors of kinases ABBVIE INC 2015-01-07 — — CN claimed
EP-2817308-A1 PYRIDOPYRIMIDINONE INHIBITORS OF KINASES AbbVie Inc. (US) 2014-12-31 — — EP claimed
CN-104011049-A Pyridopyrimidinone inhibitors of kinases ABBVIE INC 2014-08-27 — — CN claimed
CN-103703005-A Tricyclic inhibitors of kinases ABBOTT LAB 2014-04-02 — — CN claimed
EP-2681221-A1 TRICYCLIC INHIBITORS OF KINASES AbbVie Inc. (US) 2014-01-08 — — EP claimed
WO-2013126656-A1 PYRIDOPYRIMIDINONE INHIBITORS OF KINASES ABBVIE INC. (US) 2013-08-29 — — WO claimed
WO-2012161812-A1 TRICYCLIC INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2012-11-29 — — WO claimed
CN-104271576-A Pyridopyrimidinone inhibitors of kinases ABBVIE INC 2015-01-07 — — CN disclosed
EP-2817308-A1 PYRIDOPYRIMIDINONE INHIBITORS OF KINASES AbbVie Inc. (US) 2014-12-31 — — EP disclosed
CN-104011049-A Pyridopyrimidinone inhibitors of kinases ABBVIE INC 2014-08-27 — — CN disclosed
CN-103703005-A Tricyclic inhibitors of kinases ABBOTT LAB 2014-04-02 — — CN disclosed
EP-2681221-A1 TRICYCLIC INHIBITORS OF KINASES AbbVie Inc. (US) 2014-01-08 — — EP disclosed
WO-2013126656-A1 PYRIDOPYRIMIDINONE INHIBITORS OF KINASES ABBVIE INC. (US) 2013-08-29 — — WO disclosed
WO-2012161812-A1 TRICYCLIC INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2012-11-29 — — WO disclosed
Send feedback